Guangdong Taiantang Pharmaceutical Co., Ltd.

SZSE:002433.SZ

2.69 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q32012 Q22012 Q12011 Q42011 Q32011 Q22011 Q12010 Q42010 Q32010 Q22010 Q12009 Q42009 Q32009 Q22009 Q1
Revenue 67.01632.344116.881121.819139.31826.595188.509318.488191.253817.961206.806463.491775.9181,058.125885.7890.581747.5431,256.08972.347980.365804.364990.129778.228866.711680.231,024.333636.591813.7764.316911.941779.183748.467635.855762.979716.357554.012338.3426.688356.972271.882172.094256.326241.538175.645111.657166.43146.995111.76592.686129.6131.47796.61959.67398.12188.61469.00558.29591.6282.14261.29753.276
Cost of Revenue 57.57960.97792.77571.945115.499-89.383125.441283.934122.471693.654112.41323.791605.113817.021636.132637.314559.824956.473714.618787.162575.157844.125482.562618.94449.024725.017389.065587.535568.039648.843547.082575.605473.596588.156488.471401.817218.67277.983204.605184.763101.002156.305136.661112.49655.19783.98180.19162.92652.38772.82476.05256.23335.20759.06652.36742.27135.59356.71349.00937.91932.685
Gross Profit 9.437-28.63424.10649.87423.819115.97763.06834.55468.782124.30794.396139.699170.805241.104249.568253.267187.719299.607257.728193.202229.207146.004295.666247.77231.206299.316247.526226.165196.277263.098232.101172.862162.259174.823227.886152.195119.63148.705152.36787.11971.092100.021104.87863.14956.4682.44966.80448.83940.29856.77655.42540.38624.46639.05536.24726.73422.70234.90833.13423.37720.591
Gross Profit Ratio 0.141-0.8850.2060.4090.1714.3610.3350.1080.360.1520.4560.3010.220.2280.2820.2840.2510.2390.2650.1970.2850.1470.380.2860.340.2920.3890.2780.2570.2890.2980.2310.2550.2290.3180.2750.3540.3490.4270.320.4130.390.4340.360.5060.4950.4540.4370.4350.4380.4220.4180.410.3980.4090.3870.3890.3810.4030.3810.387
Reseach & Development Expenses 1.1341.352.0552.0542.01516.2653.8434.5192.09119.9732.7642.9444.7194.8794.766.5334.20811.0984.5334.8363.7946.255.298-0.9564.99114.7600000000000000000000000000000000000
General & Administrative Expenses 26.885-88.55102.832-25.69248.064-107.47126.038-32.1447.94-102.161114.966-31.09455.513-108.70655.128-37.42861.461-89.73839.17-28.59450.48-82.00242.654-25.52846.087-85.57543.223-21.16137.803-65.0233.661-18.6331.359-63.5934.144-18.94530.753-45.28623.588-8.1414.98-28.99915.035-7.46312.798-19.92410.392-2.8938.294-7.066.1650.8424.748-3.3234.9782.92.8831.9693.9643.3052.68
Selling & Marketing Expenses 14.76964.34559.9167.4925.81328.41324.00238.1727.11788.88245.529112.601122.181173.082138.828121.445115.917191.885114.953121.2882.898137.09298.194132.84678.069129.91767.87679.7673.15108.79979.6876.94369.0499.4677.87474.83843.72669.26127.56322.58411.71332.58823.50521.82415.32212.89917.82714.2816.04415.79919.0620.0395.04413.6335.03517.2234.5725.7915.49613.064.613
SG&A 35.817-24.206162.74141.79873.877-79.057150.0396.0375.057-13.28160.49581.507177.69464.375193.95584.017177.378102.147154.12392.686133.37855.091140.848107.317124.15644.342111.09858.598110.95343.779113.34158.314100.39935.87112.01855.89374.47923.97651.1514.44426.6933.58938.5414.36128.12-7.02528.21911.38714.3388.73925.22520.8819.79110.30910.01320.1237.4557.769.4616.3657.293
Other Expenses 8.064-95.83618.008-6.1214.236132.005-66.3566.1348.526-36.82232.221-2.046-0.3580.907-0.458-2.18-2.505-2.585-1.347-0.3570.98-2.8221.39770.0130.15535.13410.71546.2081.4539.4781.23345.7471.5862.578-0.7630.7520.5931.830.4260.7491.2432.4570.715-0.3410.6681.338.3470.090.111-0.9540.574-0.6561.2351.801-0.6753.2540.3495.2190.020.5560.19
Operating Expenses 36.951136.642110.054100.86980.12869.21387.53376.68385.674178.09785.02163.218190.668236.001200.492166.145181.873272.752162.442158.639138.747194.804153.334188.174130.52189.461119.146125.672118.994159.579118.321120.647103.195147.091114.803106.19775.88894.04153.2847.25728.0449.11340.24536.6728.98532.07329.47229.84914.85727.61926.43527.47310.36121.15710.68620.67.858.41510.01916.7857.7
Operating Income -27.514-1,924.361-171.784-38.894-78.812-639.721-24.465-42.129-16.892-1,423.89419.465635.659-66.453-28.49328.39419.68622.6928.05458.5976.99753.777128.743112.08313.84574.79970.39897.77177.49458.67192.04391.31637.51945.24220.862110.7144.68442.86340.45293.01333.39436.67841.38359.7925.67626.20340.34329.62714.49618.20130.57528.73612.52712.97223.00524.9931.77313.87426.82921.4954.42411.958
Operating Income Ratio -0.411-59.497-1.47-0.319-0.566-24.054-0.13-0.132-0.088-1.7410.0941.371-0.086-0.0270.0320.0220.030.0060.060.0070.0670.130.1440.0160.110.0690.1540.0950.0770.1010.1170.050.0710.0270.1550.0810.1270.0950.2610.1230.2130.1610.2480.1460.2350.2420.2020.130.1960.2360.2190.130.2170.2340.2820.0260.2380.2930.2620.0720.224
Total Other Income Expenses Net -28.418-1,839.1118.008-6.12112.367-10.88-9.967-51.597-24.667-36.82242.311657.132-46.947-32.689-21.14-69.61614.341-21.387-38.037-27.923-35.704174.722-28.852-45.362-25.733-4.322-19.894-20.437-17.159-2.047-21.232.084-12.237-4.421-3.178-0.563-0.285-12.383-5.647-5.72-5.13-7.137-4.127-1.143-0.605-9.2970.643-4.403-7.131.860.3190.0990.1027.542-1.243-3.113-0.6291.895-1.6-1.613-0.743
Income Before Tax -55.932-2,020.198-153.777-45.015-66.445-650.601-34.432-93.725-41.558-1,460.71651.687633.614-66.811-27.58627.93617.50620.1875.46957.256.6454.756125.922113.4814.23474.954105.534108.48680.05660.124101.47292.54954.29946.82823.311109.90545.43643.45642.28193.4434.14337.92243.77160.50525.33526.87141.07937.97514.58618.31131.01729.30913.01114.20725.4424.3183.02114.22228.38721.5154.9812.148
Income Before Tax Ratio -0.835-62.46-1.316-0.37-0.477-24.463-0.183-0.294-0.217-1.7860.251.367-0.086-0.0260.0320.020.0270.0040.0590.0070.0680.1270.1460.0160.110.1030.170.0980.0790.1110.1190.0730.0740.0310.1530.0820.1280.0990.2620.1260.220.1710.250.1440.2410.2470.2580.1310.1980.2390.2230.1350.2380.2590.2740.0440.2440.310.2620.0810.228
Income Tax Expense -1.9812.77-1.3631.846-3.93639.0010.439-5.875-0.307-82.7759.63663.426-0.592-5.4599.2815.1242.209-7.35116.274-0.4913.85711.70924.4120.45216.83621.67415.39214.6718.14819.2211.6724.5666.815.5589.1474.3057.519-4.65911.4272.8925.753.8855.0624.7625.47810.445.1332.8023.0932.7434.3164.3032.0293.9384.427-0.1012.2885.7043.1352.122.226
Net Income -54.812-1,956.407-147.582-44.654-62.51-689.602-34.871-87.851-41.251-1,356.02233.13578.788-59.185-18.30314.09510.78415.6517.67335.2147.53335.674116.4585.99212.7855.6784.93791.86363.23550.36479.10778.13947.88538.19818.85896.50840.05834.69949.53277.03129.58630.15839.53853.60619.72220.0327.8731.97412.31115.89828.27424.9938.70812.17821.50219.8913.12211.93422.68318.382.8619.967
Net Income Ratio -0.818-60.488-1.263-0.367-0.449-25.93-0.185-0.276-0.216-1.6580.161.249-0.076-0.0170.0160.0120.0210.0140.0360.0080.0440.1180.110.0150.0820.0830.1440.0780.0660.0870.10.0640.060.0250.1350.0720.1030.1160.2160.1090.1750.1540.2220.1120.1790.1670.2180.110.1720.2180.190.090.2040.2190.2240.0450.2050.2480.2240.0470.187
EPS -0.072-2.56-0.19-0.058-0.082-0.9-0.047-0.12-0.05500.0450.78-0.08-0.0260.020.0140.020.020.040.0110.050.150.110.0160.070.110.120.0880.070.10.10.0630.050.0270.090.0580.050.0840.130.110.110.0740.20.0690.070.070.160.0310.040.0710.0630.0220.030.0540.050.0110.040.0770.0630.0090.033
EPS Diluted -0.072-2.56-0.19-0.058-0.082-0.9-0.047-0.12-0.05500.0450.78-0.08-0.0260.020.0140.020.020.040.0110.050.150.110.0160.070.110.120.0880.070.10.10.0630.050.0270.090.0580.050.0840.130.110.110.0740.20.0690.070.070.160.0310.040.0710.0630.0220.030.0540.050.0110.040.0770.0630.0090.033
EBITDA -27.937-208.422-101.605-59.836-49.88326.829-25.088-50.013-20.615-878.66479.629691.744-23.80325.54346.91882.76229.94963.65293.6232.61588.528214.265143.91952.487101.006159.079131.541101.53674.612132.099117.36968.01259.55537.316114.5549.79643.98665.57699.22841.46944.14457.76765.72728.74128.43355.85739.29219.03328.31332.95530.13614.63915.23620.78726.0514.45614.85226.56724.1066.59312.891
EBITDA Ratio -0.417-6.444-0.869-0.491-0.3581.009-0.133-0.157-0.108-1.0740.3851.492-0.0310.0240.0530.0930.040.0510.0960.0330.110.2160.1850.0610.1480.1550.2070.1250.0980.1450.1510.0910.0940.0490.160.090.130.1540.2780.1530.2570.2250.2720.1640.2550.3360.2670.170.3050.2540.2290.1520.2550.2120.2940.0650.2550.290.2930.1080.242